drugset
drugset / Trial / NCT05943327

A Study Investigating Lu AG06474 in Healthy Young Participants

NCT05943327 ↗

Phase 1 Terminated 56 enrolled H. Lundbeck A/S
RandomizedSequentialQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the safety of multiple oral doses of Lu AG06474, how well the doses are tolerated, and what the body does to the drug after administering it to healthy young participants. This study also aims to compare how the body absorbs and uses Lu AG06474 when it is given in capsule form versus when it is given as an oral solution.

Timeline

Start
2023-06-28
Primary completion
2024-07-19
Completion
2024-07-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG06474 Unknown — Oral

Indications

No indication recorded.